Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

Publikation

Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

Wissenschaftlicher Artikel/Review - 08.12.2019

Olearo Flaminia, D'arminio Monforte Antonella, Zazzi Maurizio, Rossetti Barbara, Neau Didier, Bellecave Pantxika, Rijnders Bart, Reiss Peter, Wit Ferdinand, Kouyos Roger, Boeni Jürg, Bernasconi Enos, Günthard Huldrych F, Nguyen Huyen, Bonnet Fabrice, Yerly Sabine, Wandeler Gilles, Stoeckle Marcel, Cavassini Matthias, Scherrer Alexandra, Costagliola Dominique, Schmid Patrick, Calmy Alexandra

Zitation

Olearo F, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Boeni J, Bernasconi E, Günthard H, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagliola D, Schmid P, Calmy A. Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz500.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Open Forum Infect Dis 2019; 6

Veröffentlichungsdatum

08.12.2019

ISSN (Druck)

2328-8957

Seiten

ofz500

Kurzbeschreibung/Zielsetzung

[This corrects the article DOI: 10.1093/ofid/ofz330.][This corrects the article DOI: 10.1093/ofid/ofz330.].